Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Vesole

Showing results (21-30 of 148) with videos related to

Pageof 15
Sort By:
Leukemia & Lymphoma|August 1, 2024
Venetoclax-based induction therapy for primary plasma cell leukemia with high BCL-2 expressionCharalampos Charalampous, Kimberley Doucette, Aimee Chappell, et al.
Clinical Lymphoma & Myeloma|October 10, 2006
Engraftment syndrome after hematopoietic stem cell transplantation in multiple myelomaJed Abraham Katzel, Amitabha Mazumder, Sundar Jagannath, et al.
Clinical Lymphoma & Myeloma|July 25, 2008
Association between renal cell carcinoma and plasma cell dyscrasias: a case series of six patientsMeghana S Bhandari, Amitabha Mazumder, Sundar Jagannath, et al.
Hematological Oncology|March 29, 2016
Safety and tolerability of pomalidomide-based regimens (pomalidomide-carfilzomib-dexamethasone with or without cyclophosphamide) in relapsed/refractory multiple myeloma and severe renal dysfunction: a case seriesJoshua Richter, Noa Biran, Narjust Duma, et al.
Leukemia & Lymphoma|January 25, 2022
Venetoclax in upfront induction therapy for primary plasma cell leukemia with t(11;14) or BCL2 expressionTina Roy, Joseph B An, Kimberly Doucette, et al.
Blood|February 15, 2007
Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implicationsRadek Spisek, Anna Charalambous, Amitabha Mazumder, et al.
Leukemia & Lymphoma|October 20, 2021
Use of eculizumab in autologous hematopoietic stem cell transplantation-associated thrombotic microangiopathy in two adultsMohammad Alhomoud, Aquino Williams, Cynthia Magro, et al.
Journal of Clinical Medicine|November 11, 2022
Effect of a 6-Week Cycle of Nordic Walking Training on Vitamin 25(OH)D<sub>3,</sub> Calcium-Phosphate Metabolism and Muscle Damage in Multiple Myeloma Patients-Randomized Controlled TrialOlga Czerwińska-Ledwig, David H Vesole, Anna Piotrowska, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2013
Intermittent zoledronic Acid prevents bone loss in adults after allogeneic hematopoietic cell transplantationParameswaran Hari, Todd E DeFor, David H Vesole, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 1, 2010
Intracranial multifocal dural involvement in multiple myeloma: case report and review of the literatureCarlos E Méndez, Becky J Hwang, Sylvie Destian, et al.
Pageof 15

Showing results (21-30 of 148) with videos related to

Sort By:
Pageof 15
Leukemia & Lymphoma|August 1, 2024
Venetoclax-based induction therapy for primary plasma cell leukemia with high BCL-2 expressionCharalampos Charalampous, Kimberley Doucette, Aimee Chappell, et al.
Clinical Lymphoma & Myeloma|October 10, 2006
Engraftment syndrome after hematopoietic stem cell transplantation in multiple myelomaJed Abraham Katzel, Amitabha Mazumder, Sundar Jagannath, et al.
Clinical Lymphoma & Myeloma|July 25, 2008
Association between renal cell carcinoma and plasma cell dyscrasias: a case series of six patientsMeghana S Bhandari, Amitabha Mazumder, Sundar Jagannath, et al.
Hematological Oncology|March 29, 2016
Safety and tolerability of pomalidomide-based regimens (pomalidomide-carfilzomib-dexamethasone with or without cyclophosphamide) in relapsed/refractory multiple myeloma and severe renal dysfunction: a case seriesJoshua Richter, Noa Biran, Narjust Duma, et al.
Leukemia & Lymphoma|January 25, 2022
Venetoclax in upfront induction therapy for primary plasma cell leukemia with t(11;14) or BCL2 expressionTina Roy, Joseph B An, Kimberly Doucette, et al.
Blood|February 15, 2007
Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implicationsRadek Spisek, Anna Charalambous, Amitabha Mazumder, et al.
Leukemia & Lymphoma|October 20, 2021
Use of eculizumab in autologous hematopoietic stem cell transplantation-associated thrombotic microangiopathy in two adultsMohammad Alhomoud, Aquino Williams, Cynthia Magro, et al.
Journal of Clinical Medicine|November 11, 2022
Effect of a 6-Week Cycle of Nordic Walking Training on Vitamin 25(OH)D<sub>3,</sub> Calcium-Phosphate Metabolism and Muscle Damage in Multiple Myeloma Patients-Randomized Controlled TrialOlga Czerwińska-Ledwig, David H Vesole, Anna Piotrowska, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2013
Intermittent zoledronic Acid prevents bone loss in adults after allogeneic hematopoietic cell transplantationParameswaran Hari, Todd E DeFor, David H Vesole, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 1, 2010
Intracranial multifocal dural involvement in multiple myeloma: case report and review of the literatureCarlos E Méndez, Becky J Hwang, Sylvie Destian, et al.
Pageof 15